InvestorsHub Logo
Followers 14
Posts 1160
Boards Moderated 0
Alias Born 12/19/2008

Re: prsch3259 post# 11329

Friday, 03/06/2009 7:43:07 PM

Friday, March 06, 2009 7:43:07 PM

Post# of 58465
The "overwhelming"

...statement was in reference to Genasense performance in the treatment of melanoma, the Agenda Trial....not CLL.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.